BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 18, 2025
Home
»
Topics
»
Disease categories and therapies
» Neurology/psychiatric
Neurology/psychiatric
RSS
5-HT2B/2C antagonists reported by SmithKline Beecham
June 14, 1996
Further ADIR research on melatonergic compounds
June 14, 1996
Zeneca reveals prostaglandin antagonists
June 14, 1996
ADIR claims tachykinin antagonists
June 14, 1996
Dopamine D4 receptor ligands discovered by Pfizer
June 7, 1996
Clinical trials anticipated for CoCensys' and Ciba-Geigy's codeveloped EAA antagonist
June 7, 1996
Ciba-Geigy discloses glycine-site NMDA antagonists
June 7, 1996
BASF reports glutamate receptor antagonists
June 7, 1996
GR-205171: A non-peptide neurokinin NK1 antagonist
June 7, 1996
ADIR reports piperazines with affinity for sigma-receptors
June 7, 1996
Previous
1
2
…
2893
2894
2895
2896
2897
2898
2899
2900
2901
…
2914
2915
Next